Table 6.
Cox proportional hazard regression predictors of outcome | |||||
---|---|---|---|---|---|
Including biplane LAEF | Including SAX LAEF | ||||
Hazard ratio (95%CI) | P value | Hazard ratio (95%CI) | P value | ||
Clinical | |||||
Age | 1.126 (0.771–1.645) | 0.538 | Age | 1.049 (0.708–1.555) | 0.811 |
Average diastolic BP | 0.606 (0.407–0.904) | 0.014 | Average diastolic BP | 0.580 (0.390–0.863) | 0.007 |
Prior HF hospitalization | 1.693 (0.810–3.540) | 0.162 | Prior HF hospitalization | 1.588 (0.754–3.347) | 0.224 |
6MWT distance | 0.596 (0.372–0.956) | 0.032 | 6MWT distance | 0.613 (0.387–0.972) | 0.038 |
+ Biplane LAEF | 0.535 (0.385–0.744) | < 0.0001 | + SAX LAEF | 0.532 (0.391–0.724) | < 0.0001 |
Clinical blood samples | |||||
Log creatinine (umol/L) | 1.035 (0.731–1.466) | 0.0847 | Log creatinine (umol/L) | 1.033 (0.734–1.454) | 0.853 |
Haemoglobin (g/L) | 0.805 (0.584–1.109) | 0.155 | Haemoglobin (g/L) | 0.677 (0.496–0.923) | 0.114 |
Log BNP (ng/L) | 1.126 (0.712–1.782) | 0.611 | Log BNP (ng/L) | 1.128 (0.712–1.787) | 0.607 |
Log NTpro-ANP | 1.373 (0.990–1.906) | 0.058 | NTpro-ANP | 1.244 (0.890–1.739) | 0.202 |
+ Biplane LAEF | 0.649 (0.456–0.924) | 0.016 | + SAX LAEF | 0.552 (0.410–0.741) | < 0.0001 |
Imaging | |||||
LV mass index | 0.582 (0.217–1.560) | 0.282 | LV mass index | 0.529 (0.205–1.366) | 0.188 |
LAVI max | 0.961 (0.599–1.541) | 0.869 | LAVI max | 0.997 (0.630–1.577) | 0.988 |
iECV | 1.558 (1.097–2.213) | 0.013 | iECV | 1.564 (1.106–2.211) | 0.011 |
+ Biplane LAEF | 0.575 (0.419–0.788) | 0.001 | + SAX LAEF | 0.668 (0.472–0.944) | 0.022 |
Strongest markers combined | |||||
Average diastolic BP | 0.723 (0.461–1.134) | 0.158 | Average diastolic BP | 0.725 (0.461–1.139) | 0.163 |
6MWT distance | 0.611 (0.354–1.053) | 0.076 | 6MWT distance | 0.592 (0.346–1.011) | 0.055 |
iECV | 1.491 (1.038–2.143) | 0.031 | iECV | 1.584 (1.110–2.260) | 0.011 |
+ Biplane LAEF | 0.604 (0.406–0.900) | 0.013 | + SAX LAEF | 0.636 (0.441–0.918) | 0.016 |